Caribou Biosciences, Inc.
CRBU
$1.84
$0.000.00%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 9.90% | 0.66% | -6.08% | -33.07% | -28.29% |
| Total Depreciation and Amortization | -28.59% | -7.18% | 19.06% | 20.80% | 20.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 184.56% | 180.95% | 108.35% | 140.59% | -22.50% |
| Change in Net Operating Assets | 31.63% | 90.54% | -257.95% | 46.33% | 0.76% |
| Cash from Operations | 26.48% | 19.69% | -1.23% | -10.71% | -34.29% |
| Capital Expenditure | 91.31% | 72.15% | 68.47% | 75.27% | 59.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -34.27% | 13.25% | 123.11% | 362.90% | 314.01% |
| Cash from Investing | -32.02% | 18.05% | 155.59% | 307.67% | 271.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 49.76% | -71.17% | -64.12% | -96.90% | -97.15% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.76% | -71.17% | -64.00% | -96.90% | -97.15% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.13% | 88.72% | 71.11% | 55.29% | -497.58% |